Samsung Biologics & Merck’s strategic agreement of manufacturing biologics

Published: 2017-11-03 15:29:23

Updated: 2017-11-03 15:29:23

A pharmaceutical and chemical company Merck announced on the 2nd the company signed a memorandum of understanding(MOU) to agree on strategically manufacture biologics and develop their manufacturing process with Samsung Biologics.

This MOU, an extension of the MOU they established in 2014, contains terms and conditions about the Merck’s supply of ingredients that are necessary to manufacture b...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.